Abstract:Phage display is a versatile method often used in the discovery of peptides that targets disease-related biomarkers. A major advantage of this technology is the ease and cost efficiency of affinity selection, also known as biopanning, to identify novel peptides. While it is relatively straightforward to identify peptides with optimal binding affinity, the pharmacokinetics of the selected peptides often prove to be suboptimal. Therefore, careful consideration of the experimental conditions, including the choice of using in vitro, in situ, or in vivo affinity selections, is essential in generating peptides with high affinity and specificity that also demonstrate desirable pharmacokinetics. Specifically, in vivo biopanning, or the combination of in vitro, in situ, and in vivo affinity selections, has been proven to influence the biodistribution and clearance of peptides and peptide-conjugated nanoparticles. Additionally, the marked difference in properties between peptides and nanoparticles must be considered. While peptide biodistribution depends primarily on physiochemical properties and can be modified by amino acid modifications, the size and shape of nanoparticles also affect both absorption and distribution. Thus, optimization of the desired pharmacokinetic properties should be an important consideration in biopanning strategies to enable the selection of peptides and peptide-conjugated nanoparticles that effectively target biomarkers in vivo.

Advantages of mRNA display selections over other selection techniques for investigation of protein–protein interactions

mRNA display: ligand discovery, interaction analysis and beyond

The Display Technologies of Molecular Libraries

Chemical Stability of mRNA/cDNA Complexes: Defining the Limits of mRNA display

Advances of study of protein-protein interactions

Applications of display technology in protein analysis

Advancement and applications of peptide phage display technology in biomedical science

Advances in Studies on Phage Display Systems

mRNA Display Pipeline for Protein Biosensor Construction

mRNA display in cell lysates enables identification of cyclic peptides targeting the BRD3 extraterminal domain

DNA display for drug discovery

Combining Chemical Protein Synthesis and Random Nonstandard Peptides Integrated Discovery for Modulating Biological Processes

In vivo mRNA display enables large-scale proteomics by next generation sequencing

Application of Yeast Cell-surface Display for Protein Engineering

Identification of photocrosslinking peptide ligands by mRNA display

Phage Display Technology and Its Applications in Cancer Immunotherapy

Improving Pharmacokinetics of Peptides Using Phage Display

Selection of Functional Protein Using Ribosome Display

Construction and Applications of Mammalian Cell-Based DNA-Encoded Peptide/Protein Libraries.

A membrane protein display platform for receptor interactome discovery